State Of The Science At FDA: Catching Up With Jesse Goodman
Executive Summary
As the swine flu pandemic shows signs of leveling off, FDA Chief Scientist Jesse Goodman is ready to turn attention back to his original mission: improving the agency's scientific capacity and integrity
You may also be interested in...
FDA’s Acting Chief Scientist Offers Vaccine Continuity As Goodman Departs
Jesse Goodman will become director of Georgetown University’s new Center on Medical Product Access, Safety and Stewardship while Stephen Ostroff steps up as FDA’s Acting Chief Scientist.
FDA’s Acting Chief Scientist Offers Vaccine Continuity As Goodman Departs
Jesse Goodman will become director of Georgetown University’s new Center on Medical Product Access, Safety and Stewardship while Stephen Ostroff steps up as FDA’s Acting Chief Scientist.
FDA Regulatory Science Infrastructure Gets $25 Million Push In Budget
Gaining the expertise and infrastructure needed to assess products of the future - such as biosimilars and those based on stem cells and nanotechnology - is the goal of a $25 million scientific modernization effort proposed in the fiscal 2011 FDA budget